VidaMed shareholders file complaint over Medtronic deal
This article was originally published in Clinica
Executive Summary
VidaMed has rejected accusations, believed to be filed by its shareholders, concerned with its recently-announced plans to be bought by Medtronic. The Fremont, California company says the complaints include breach of fiduciary duty by its directors in relation to the proposed merger. Three complaints have been filed against the company, its directors and Medtronic. VidaMed will defend its position.